Adaptation to chronic hypoxia represents a potential cardioprotective intervention reducing the extent of acute ischemia/reperfusion (I/R) injury, which is a major cause of death worldwide. The main objective of this study was to investigate the anti-apoptotic Akt/hexokinase 2 (HK2) pathway in hypoxic hearts subjected to I/R insult. Hearts isolated from male Wistar rats exposed either to continuous normobaric hypoxia (CNH; 10% O2) or to room air for 3 weeks were perfused according to Langendorff and subjected to 10 min of no-flow ischemia and 10 min of reperfusion. The hearts were collected either after ischemia or after reperfusion and used for protein analyses and quantitative fluorescence microscopy. The CNH resulted in increased levels of HK1 and HK2 proteins and the total HK activity after ischemia compared to corresponding normoxic group. Similarly, CNH hearts exhibited increased ischemic level of Akt protein phosphorylated on Ser473. The CNH also strengthened the interaction of HK2 with mitochondria and prevented downregulation of mitochondrial creatine kinase after reperfusion. The Bax/Bcl-2 ratio was significantly lower after I/R in CNH hearts than in normoxic ones, suggesting a lower probability of apoptosis. In conclusion, the Akt/HK2 pathway is likely to play a role in the development of a cardioprotective phenotype of CNH by preventing the detachment of HK2 from mitochondria at reperfusion period and decreases the Bax/Bcl-2 ratio during I/R insult, thereby lowering the probability of apoptosis activation in the mitochondrial compartment.

Department of Physiology Faculty of Science Charles University Prague Prague Czech Republic

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

J Biol Chem. 2003 May 16;278(20):17760-6 PubMed

EMBO J. 1996 Dec 2;15(23):6541-51 PubMed

J Mol Cell Cardiol. 2015 Jan;78:129-41 PubMed

Biochim Biophys Acta. 2002 Sep 10;1555(1-3):14-20 PubMed

J Bioenerg Biomembr. 2008 Jun;40(3):171-82 PubMed

Trends Endocrinol Metab. 2015 Aug;26(8):422-9 PubMed

Physiol Genomics. 2015 Dec;47(12 ):612-20 PubMed

J Biol Chem. 2003 Jan 10;278(2):1125-30 PubMed

J Biol Chem. 1974 Mar 10;249(5):1341-7 PubMed

Circ Res. 2011 May 13;108(10):1165-9 PubMed

Biochim Biophys Acta. 2009 May;1787(5):421-30 PubMed

J Appl Physiol (1985). 1999 Nov;87(5):1990-5 PubMed

Oncogene. 1998 Jul 23;17(3):313-25 PubMed

Cell. 2012 Feb 3;148(3):399-408 PubMed

Biochim Biophys Acta. 2005 Dec 20;1710(2-3):78-86 PubMed

Cell Physiol Biochem. 2014;33(2):310-20 PubMed

J Neurosci. 2004 Nov 3;24(44):9993-10002 PubMed

Biochim Biophys Acta. 2009 Oct;1788(10):2032-47 PubMed

Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1239-48 PubMed

J Appl Physiol (1985). 2009 Jun;106(6):1909-16 PubMed

Cell Death Differ. 2008 Mar;15(3):521-9 PubMed

Biochim Biophys Acta. 1991 Jul 8;1074(2):302-11 PubMed

J Biol Chem. 2013 Aug 16;288(33):23798-806 PubMed

Biochimie. 2008 Oct;90(10):1566-77 PubMed

Physiol Rev. 2011 Jul;91(3):1023-70 PubMed

Curr Pharm Des. 2013;19(39):6880-9 PubMed

Respir Physiol Neurobiol. 2007 Sep 30;158(2-3):224-36 PubMed

PLoS One. 2011 Mar 09;6(3):e17674 PubMed

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H378-86 PubMed

Cell. 1997 Oct 17;91(2):231-41 PubMed

Cell Physiol Biochem. 2013;31(1):66-79 PubMed

Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2770-8 PubMed

J Bioenerg Biomembr. 2009 Apr;41(2):181-5 PubMed

Cell. 2006 Oct 6;127(1):125-37 PubMed

J Biol Chem. 2006 Dec 8;281(49):37361-71 PubMed

Circ Res. 2007 Mar 2;100(4):474-88 PubMed

Antioxid Redox Signal. 2005 May-Jun;7(5-6):538-46 PubMed

J Biol Chem. 2002 Mar 1;277(9):7610-8 PubMed

PLoS One. 2008 Mar 19;3(3):e1852 PubMed

J Mol Cell Cardiol. 2008 Feb;44(2):419-28 PubMed

Nat Methods. 2012 Jun 28;9(7):676-82 PubMed

J Clin Invest. 2004 Aug;114(4):495-503 PubMed

J Physiol. 2003 Oct 15;552(Pt 2):335-44 PubMed

J Appl Physiol (1985). 2015 Dec 15;119(12 ):1487-93 PubMed

J Biol Chem. 2008 May 9;283(19):13482-90 PubMed

J Biol Chem. 2007 Jun 22;282(25):18069-82 PubMed

Genes Dev. 2001 Jun 1;15(11):1406-18 PubMed

J Am Heart Assoc. 2013 Nov 04;2(6):e000355 PubMed

Am J Transl Res. 2010 Jan 01;2(1):19-42 PubMed

Biochim Biophys Acta. 1998 Jan 5;1368(1):7-18 PubMed

Mol Cell. 2004 Dec 3;16(5):819-30 PubMed

Arch Biochem Biophys. 1984 Jul;232(1):391-9 PubMed

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004 Jun;21(3):401-5 PubMed

J Clin Invest. 1992 Nov;90(5):1972-7 PubMed

J Am Heart Assoc. 2012 Dec 31;2(1):e005645 PubMed

Lab Invest. 2015 Jan;95(1):14-25 PubMed

Curr Biol. 2000 Apr 20;10(8):439-48 PubMed

Biochem J. 2011 Jun 1;436(2):493-505 PubMed

The involvement of protein kinases in the cardioprotective effect of chronic hypoxia

Anti-arrhythmic Cardiac Phenotype Elicited by Chronic Intermittent Hypoxia Is Associated With Alterations in Connexin-43 Expression, Phosphorylation, and Distribution

Cardioprotective Regimen of Adaptation to Chronic Hypoxia Diversely Alters Myocardial Gene Expression in SHR and SHR-mtBN Conplastic Rat Strains